Cite
HARVARD Citation
Dowling, R. et al. (2015). Changes in insulin receptor signaling underlie neoadjuvant metformin administration in breast cancer: a prospective window of opportunity neoadjuvant study. Breast cancer research. 17 (1), pp. 1-12. [Online].